Business Editors
 
	   SIMPSONVILLE, S.C.--(BUSINESS WIRE)--July 31, 2000--CHESTER
HOLDINGS, Ltd. (Pink Sheets: CHES) today that it had acquired, from
the joint venture of Clyebury Pty Ltd. and Medical Laser Technologies,
Inc., the rights to market the Probity Gradient in China.
	   The Agreement, valued at $400,000, calls for Chester to issue
58,800 shares of Convertible Preferred stock to Clyebury and 61,200
shares of Convertible Preferred stock to Medical Laser Technologies,
Inc. (soon to be known as MLT International, Inc.) The Shares are
convertible, within two years, into the common stock of Chester at the
rate of 100 shares of common for each share of Preferred. The
Preferred also carry voting rights as if converted.
	   Clyebury, a privately held investment group, intends to use this
transaction to launch several pending network related projects in
China. It also intends to assist the management of Chester in renewing
their efforts to reorganize the company. Clyebury and its Board
members currently have interests in several software development and
manufacturing ventures in the province of Dalian in China.
 
	   "Safe Harbor" Statement under the Private Securities Litigation
Act of 1995; to the extent that this press release makes statements
about the future, such statements are forward looking and subject to a
number of risks and uncertainties, including, but not limited to, the
inability to meet all of the required reporting requirements. These
risks could effect the ability of the Company to complete acquisition
and successfully reorganize and resume operations as stated in any
forward looking statements by, or on behalf of the Company. There is
no assurance that the Company will be able to achieve any of its
intended objectives.
 
    --30--ac/ch*
 
    CONTACT: Forensic Research Group, Simpsonville
             Michael O'Shea, 864/962-8638